Innovative drug R&D in China

被引:0
|
作者
Jingzong Qi
Qingli Wang
Zhenhang Yu
Xin Chen
Fengshan Wang
机构
[1] Jingzong Qi and Xin Chen are at FusoGen Pharmaceuticals,
[2] 19F-A,undefined
[3] Ping An Building B,undefined
[4] 59 Machang Road,undefined
[5] Hexi District,undefined
[6] Tianjin 300203,undefined
[7] China.,undefined
[8] Qingli Wang is at the Center for Drug Evaluation,undefined
[9] State Food and Drug Administration,undefined
[10] Beijing 100038,undefined
[11] China.,undefined
[12] Zhenhang Yu is at the China National Center for Biotechnology Development,undefined
[13] Beijing 100039,undefined
[14] China.,undefined
[15] Fengshan Wang is at the Institute of Biochemical and Biotechnological Drugs,undefined
[16] School of Pharmaceutical Sciences,undefined
[17] Shandong University,undefined
[18] Jinan 250012,undefined
[19] Shandong,undefined
[20] China.,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:333 / 334
页数:1
相关论文
共 50 条
  • [1] Innovative drug R&D in China
    Qi, Jingzong
    Wang, Qingli
    Yu, Zhenhang
    Chen, Xin
    Wang, Fengshan
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) : 333 - 334
  • [2] Evolution of innovative drug R&D in China
    Guanqiao Li
    Yang Liu
    Hongxi Hu
    Shuona Yuan
    Liyun Zhou
    Xiaoyuan Chen
    Nature Reviews Drug Discovery, 2022, 21 : 553 - 554
  • [3] Innovative Drug R&D on the Rise in China
    Zhang, Jim J.
    Man, Qunjie
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (03): : 48 - 48
  • [4] FROM THE ANALYST'S COUCH Evolution of innovative drug R&D in China
    Li, Guanqiao
    Liu, Yang
    Hu, Hongxi
    Yuan, Shuona
    Zhou, Liyun
    Chen, Xiaoyuan
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (08) : 553 - 554
  • [5] Chinese innovative drug R&D trends in 2024
    Chen, Zimeng
    Zhong, Hui
    Hu, Hongxi
    Kong, Fanpu
    Liang, Wannian
    Li, Guanqiao
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (11) : 810 - 811
  • [6] Anticancer drug R&D landscape in China
    Shen Zhao
    Hongyun Zhao
    Cheng Lv
    Jifang Gong
    Jian Zhang
    Wenfeng Fang
    Jin Li
    Xichun Hu
    Yi Ba
    Binghe Xu
    Yanqiao Zhang
    Yun Fan
    Kunyan Li
    Xiaoyuan Chen
    Zhimin Yang
    Lin Shen
    Li Zhang
    Journal of Hematology & Oncology, 13
  • [7] Challenges in anticancer drug R&D in China
    Zhao, Shen
    Lv, Cheng
    Gong, Jifang
    Fang Wenfeng
    Hu, Xichun
    Ba, Yi
    Chen Xiaoyuan
    Yang Zhimin
    Lin Shen
    Li Zhang
    LANCET ONCOLOGY, 2019, 20 (02): : 183 - 186
  • [8] Anticancer drug R&D landscape in China
    Zhao, Shen
    Zhao, Hongyun
    Lv, Cheng
    Gong, Jifang
    Zhang, Jian
    Fang, Wenfeng
    Li, Jin
    Hu, Xichun
    Ba, Yi
    Xu, Binghe
    Zhang, Yanqiao
    Fan, Yun
    Li, Kunyan
    Chen, Xiaoyuan
    Yang, Zhimin
    Shen, Lin
    Zhang, Li
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [9] AstraZeneca slates drug R&D center in China
    Mullin, Rick
    CHEMICAL & ENGINEERING NEWS, 2006, 84 (23) : 11 - 11
  • [10] China R&D
    不详
    R&D MAGAZINE, 2016, : 22 - 23